208 related articles for article (PubMed ID: 24811176)
1. A splicing variant of NME1 negatively regulates NF-κB signaling and inhibits cancer metastasis by interacting with IKKβ.
You DJ; Park CR; Lee HB; Moon MJ; Kang JH; Lee C; Oh SH; Ahn C; Seong JY; Hwang JI
J Biol Chem; 2014 Jun; 289(25):17709-20. PubMed ID: 24811176
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Functional Domains in NME1L Regulation of NF-κB Signaling.
You DJ; Park CR; Mander S; Ahn C; Seong JY; Hwang JI
Mol Cells; 2016 May; 39(5):403-9. PubMed ID: 27094059
[TBL] [Abstract][Full Text] [Related]
3. NME1L Negatively Regulates IGF1-Dependent Proliferation of Breast Cancer Cells.
You DJ; Mander S; Park CR; Koo O; Lee C; Oh SH; Ahn C; Seong JY; Hwang JI
J Cell Biochem; 2016 Jun; 117(6):1454-63. PubMed ID: 26565392
[TBL] [Abstract][Full Text] [Related]
4. Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.
Hernandez L; Hsu SC; Davidson B; Birrer MJ; Kohn EC; Annunziata CM
Cancer Res; 2010 May; 70(10):4005-14. PubMed ID: 20424119
[TBL] [Abstract][Full Text] [Related]
5. Dimer of arfaptin 2 regulates NF-κB signaling by interacting with IKKβ/NEMO and inhibiting IKKβ kinase activity.
You DJ; Park CR; Furlong M; Koo O; Lee C; Ahn C; Seong JY; Hwang JI
Cell Signal; 2015 Nov; 27(11):2173-81. PubMed ID: 26296658
[TBL] [Abstract][Full Text] [Related]
6. Kelch-like Protein 21 (KLHL21) Targets IκB Kinase-β to Regulate Nuclear Factor κ-Light Chain Enhancer of Activated B Cells (NF-κB) Signaling Negatively.
Mei ZZ; Chen XY; Hu SW; Wang N; Ou XL; Wang J; Luo HH; Liu J; Jiang Y
J Biol Chem; 2016 Aug; 291(35):18176-89. PubMed ID: 27387502
[TBL] [Abstract][Full Text] [Related]
7. IKKβ regulates endothelial thrombomodulin in a Klf2-dependent manner.
Pathak R; Shao L; Chafekar SM; Feng W; Ponnappan U; Fink LM; Zhou D; Hauer-Jensen M
J Thromb Haemost; 2014 Sep; 12(9):1533-1544. PubMed ID: 25039491
[TBL] [Abstract][Full Text] [Related]
8. IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathway.
Adli M; Merkhofer E; Cogswell P; Baldwin AS
PLoS One; 2010 Feb; 5(2):e9428. PubMed ID: 20195534
[TBL] [Abstract][Full Text] [Related]
9. Nemo-like kinase (NLK) negatively regulates NF-kappa B activity through disrupting the interaction of TAK1 with IKKβ.
Li SZ; Zhang HH; Liang JB; Song Y; Jin BX; Xing NN; Fan GC; Du RL; Zhang XD
Biochim Biophys Acta; 2014 Jul; 1843(7):1365-72. PubMed ID: 24721172
[TBL] [Abstract][Full Text] [Related]
10. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation.
Zheng Z; Li H; Zhang Z; Meng J; Mao D; Bai B; Lu B; Mao P; Hu Q; Wang H
J Immunol; 2011 Sep; 187(5):2202-12. PubMed ID: 21810613
[TBL] [Abstract][Full Text] [Related]
11. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.
Yao F; Zhou W; Zhong C; Fang W
Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971
[TBL] [Abstract][Full Text] [Related]
12. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
Schmid JA; Birbach A
Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
[TBL] [Abstract][Full Text] [Related]
13. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
Liao J; Yang Z; Carter-Cooper B; Chang ET; Choi EY; Kallakury B; Liu X; Lapidus RG; Cullen KJ; Dan H
Clin Exp Metastasis; 2020 Apr; 37(2):283-292. PubMed ID: 32020377
[TBL] [Abstract][Full Text] [Related]
14. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
15. HSCARG inhibits activation of NF-kappaB by interacting with IkappaB kinase-beta.
Gan Q; Li T; Hu B; Lian M; Zheng X
J Cell Sci; 2009 Nov; 122(Pt 22):4081-8. PubMed ID: 19843583
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
Hideshima T; Ikeda H; Chauhan D; Okawa Y; Raje N; Podar K; Mitsiades C; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
Blood; 2009 Jul; 114(5):1046-52. PubMed ID: 19436050
[TBL] [Abstract][Full Text] [Related]
17. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein.
Chen Y; Zhang J; Ge X; Du J; Deb DK; Li YC
J Biol Chem; 2013 Jul; 288(27):19450-8. PubMed ID: 23671281
[TBL] [Abstract][Full Text] [Related]
19. IKKbeta-mediated nuclear factor-kappaB activation attenuates smac mimetic-induced apoptosis in cancer cells.
Bai L; Chen W; Chen W; Wang X; Tang H; Lin Y
Mol Cancer Ther; 2009 Jun; 8(6):1636-45. PubMed ID: 19509265
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
